LINC01826

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, LINC01826 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC01826’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC01826 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01826 is over-expressed in tumor.

BRCA and KIRC are the cancer types where LINC01826 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01826 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
BRCAAllAll+0.016.0382view →
KIRCAllAll+0.009.0321view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

LINC01826–BRCA

Tumor-vs-normal expression box plot for LINC01826 RNA in BRCA.

Open the BRCA breakdown →

Exploration